Full-year gross margin is expected to be approximately 72%, compared to 71% for full-year 2024.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CTSO:
- Cytosorbents Corp’s Earnings Call: Growth Amid Challenges
- CytoSorbents price target lowered to 75c from $1 at H.C. Wainwright
- CytoSorbents Reports Strong Q3 2025 Growth and Strategic Advances
- CytoSorbents reports Q3 adjusted EPS (4c), consensus (5c)
- CytoSorbents implemented workforce and cost reduction program